Overview

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

Status:
Completed
Trial end date:
2017-12-08
Target enrollment:
Participant gender:
Summary
This trial is conducted globally. The aim of this trial is to investigate efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes mellitus treated with diet and exercise only.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S